Altered thiol/disulfide homeostasis and ischemia-modified albumin levels in children with irritable bowel syndrome

Pediatr Int. 2021 Mar;63(3):300-305. doi: 10.1111/ped.14406. Epub 2021 Mar 16.

Abstract

Background: In this study, we assessed thiol/disulfide homeostasis (TDH) parameters and ischemia-modified albumin (IMA) levels in children with irritable bowel syndrome (IBS) compared with healthy children.

Methods: Fifty-six children with IBS and 53 healthy children were included in the study after assessment of inclusion and exclusion criteria. Plasma thiol/disulfide and IMA levels were compared between children with and without IBS.

Results: The mean values of native thiol, total thiol, and disulfide were 343.779 ± 138.654 μmol/L, 365.398 ± 140.148 μmol/L, and 23.190 ± 4.978 μmol/L, respectively, in the IBS group and 409.908 ± 69.288 μmol/L, 433.481 ± 76.891 μmol/L, and 20.090 ± 4.252 μmol/L, respectively, in the control group. Native thiol and total thiol values were significantly reduced in the IBS group compared with the control group. The mean IMA values were 0.835 ± 0.083 (g/L) and 0.778 ± 0.072 in the IBS and control groups, respectively. The IMA value was significantly increased in the IBS group.

Conclusion: Impaired thiol/disulfide homeostasis and increased IMA levels can be considered etiological factors in children with IBS.

Keywords: irritable bowel syndrome; oxidative stress; thiol.

MeSH terms

  • Biomarkers / metabolism
  • Child
  • Disulfides
  • Homeostasis
  • Humans
  • Irritable Bowel Syndrome*
  • Oxidative Stress
  • Serum Albumin
  • Serum Albumin, Human
  • Sulfhydryl Compounds

Substances

  • Biomarkers
  • Disulfides
  • Serum Albumin
  • Sulfhydryl Compounds
  • ischemia-modified albumin
  • Serum Albumin, Human